NM
Neurosteer Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Neurosteer Cognitive Decline Screening | Early detection of Alzheimer’s disease | Phase 2 |
| Neurosteer Parkinson’s Monitoring | Parkinson’s disease progression | Phase 2 |
| Neurosteer Epilepsy Detection | Seizure monitoring and prediction | Phase 1 |
| Neurosteer Stress & Anxiety Biomarkers | Stress and anxiety assessment | Phase 1 |
| Neurosteer Neonatal Brain Maturity | Premature infant brain development | Preclinical |